Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Szlachtycz

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
BJC Reports|November 6, 2025
Somatic DICER1 pathogenic variants detected in a well-differentiated fetal lung adenocarcinoma diagnosed in a man with familial adenomatous polyposisAfrida Ahmed, Paul S Thorner, Anne-Laure Chong, et al.
Lung Cancer (Amsterdam, Netherlands)|May 20, 2023
Germline EGFR c.2527G > A (p.V843I) variant and familial lung cancerSaba Alsaddah, Andreas I Papadakis, Nora Wong, et al.
Haematologica|March 23, 2023
Molecular targeting of the UDP-glucuronosyltransferase enzymes in high-eukaryotic translation initiation factor 4E refractory/relapsed acute myeloid leukemia patients: a randomized phase II trial of vismodegib, ribavirin with or without decitabineSarit Assouline, Jadwiga Gasiorek, Julie Bergeron, et al.
JAMA Network Open|September 3, 2024
Universal Genetic Testing for Newly Diagnosed Invasive Breast CancerZoulikha Rezoug, Stephanie P Totten, David Szlachtycz, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
BJC Reports|November 6, 2025
Somatic DICER1 pathogenic variants detected in a well-differentiated fetal lung adenocarcinoma diagnosed in a man with familial adenomatous polyposisAfrida Ahmed, Paul S Thorner, Anne-Laure Chong, et al.
Lung Cancer (Amsterdam, Netherlands)|May 20, 2023
Germline EGFR c.2527G > A (p.V843I) variant and familial lung cancerSaba Alsaddah, Andreas I Papadakis, Nora Wong, et al.
Haematologica|March 23, 2023
Molecular targeting of the UDP-glucuronosyltransferase enzymes in high-eukaryotic translation initiation factor 4E refractory/relapsed acute myeloid leukemia patients: a randomized phase II trial of vismodegib, ribavirin with or without decitabineSarit Assouline, Jadwiga Gasiorek, Julie Bergeron, et al.
JAMA Network Open|September 3, 2024
Universal Genetic Testing for Newly Diagnosed Invasive Breast CancerZoulikha Rezoug, Stephanie P Totten, David Szlachtycz, et al.
Pageof 1